American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and …

K Cusi, S Isaacs, D Barb, R Basu, S Caprio… - Endocrine Practice, 2022 - Elsevier
Objective To provide evidence-based recommendations regarding the diagnosis and
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement

M Eslam, N Alkhouri, P Vajro, U Baumann… - The lancet …, 2021 - thelancet.com
The term non-alcoholic fatty liver disease (NAFLD), and its definition, have limitations for
both adults and children. The definition is most problematic for children, for whom alcohol …

Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity

SE Hampl, SG Hassink, AC Skinner, SC Armstrong… - …, 2023 - publications.aap.org
You have in your hands, or at your fingertips, the first edition of the American Academy of
Pediatrics clinical practice guideline for evaluation and management of children and …

Obesity I: Overview and molecular and biochemical mechanisms

RH Lustig, D Collier, C Kassotis, TA Roepke… - Biochemical …, 2022 - Elsevier
Obesity is a chronic, relapsing condition characterized by excess body fat. Its prevalence
has increased globally since the 1970s, and the number of obese and overweight people is …

Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries

GJ Martinez, M Appleton, ZA Kipp… - Physiological …, 2024 - journals.physiology.org
The normal stress response in humans is governed by the hypothalamic-pituitary-adrenal
(HPA) axis through heightened mechanisms during stress, raising blood levels of the …

Pediatric obesity: complications and current day management

ME Vajravelu, E Tas, S Arslanian - Life, 2023 - mdpi.com
Obesity affects approximately 1 in 5 youth globally and increases the risk of complications
during adolescence and young adulthood, including type 2 diabetes, dyslipidemia …

[HTML][HTML] A natural history study of paediatric non-alcoholic fatty liver disease over 10 years

L Draijer, M Voorhoeve, M Troelstra, A Holleboom… - JHEP Reports, 2023 - Elsevier
Background & Aims The long-term outcome of paediatric non-alcoholic fatty liver disease
(NAFLD) has not been well established. Between 2008 and 2012, an unselected cohort of …

Intensive lifestyle management improves steatosis and fibrosis in pediatric nonalcoholic fatty liver disease

S Lefere, E Dupont, A De Guchtenaere… - Clinical …, 2022 - Elsevier
Background & Aims Childhood obesity, with associated comorbidities such as nonalcoholic
fatty liver disease (NAFLD), is an increasing global health problem. Although lifestyle …

Suppressing hepatic UGT1A1 increases plasma bilirubin, lowers plasma urobilin, reorganizes kinase signaling pathways and lipid species and improves fatty liver …

EA Bates, ZA Kipp, GJ Martinez, OO Badmus… - Biomolecules, 2023 - mdpi.com
Several population studies have observed lower serum bilirubin levels in patients with non-
alcoholic fatty liver disease (NAFLD). Yet, treatments to target this metabolic phenotype have …

Zonation in NASH–A key paradigm for understanding pathophysiology and clinical outcomes

JB Steinman, MA Salomao, UB Pajvani - Liver International, 2021 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) exists as a spectrum ranging from simple
steatosis to histologically defined hepatocyte injury and inflammatory changes that define …